Cell Therapy Processing Global Market Report 2025

Description

Cell therapy processing refers to the sequence of procedures involved in collecting, modifying, and preparing living cells for therapeutic applications. This process includes cell isolation, activation, genetic modification, expansion, and formulation, all carried out under strict sterile and quality-controlled conditions. To ensure safety, purity, and effectiveness, these steps are performed in accordance with good manufacturing practices (GMP).

The primary offerings in cell therapy processing include products, services, and software. Products consist of physical tools, reagents, cell lines, and advanced instruments used to handle, cultivate, and prepare cells. Applications span across areas such as cardiovascular therapies, bone repair, neurological disorders, skeletal muscle repair, cancer treatment, and more. End users include research institutes, biopharmaceutical companies, contract research organizations (CROs), and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cell therapy processing market research report is one of a series of new reports from The Business Research Company that provides cell therapy processing market statistics, including cell therapy processing industry global market size, regional shares, competitors with a cell therapy processing market share, detailed cell therapy processing market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy processing industry. This cell therapy processing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy processing market size has grown rapidly in recent years. It will grow from $4.54 billion in 2024 to $5.18 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to the increasing adoption of cell-based therapies, greater investment in biomanufacturing infrastructure, rising demand for personalized medicine, growing clinical success of cell therapies, and the heightened need for good manufacturing practice (GMP)-compliant processing systems.

The cell therapy processing market size is expected to see rapid growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the increasing focus on automated cell processing technologies, the rising integration of artificial intelligence (AI) into cell manufacturing workflows, growing demand for scalable allogeneic cell therapies, stronger regulatory support for advanced therapy manufacturing, and the expansion of partnerships between biotech firms and contract development and manufacturing organizations (CDMOs). Key trends anticipated during this period include advancements in closed-system bioreactor technologies, the development of real-time monitoring tools for cell cultures, innovations in cryopreservation and cell storage methods, progress in cell separation and purification techniques, and the emergence of modular and scalable good manufacturing practice (GMP) manufacturing platforms.

The rising number of cell therapy research activities is expected to drive the growth of the cell therapy processing market in the coming years. Cell therapy refers to the development and manufacturing of therapeutic products derived from living cells to treat or manage diseases such as cancers, autoimmune disorders, and genetic conditions. Growing demand for scalable and consistent manufacturing platforms that can support high cell densities without compromising quality is fueling research activity. Cell therapy processing plays a critical role by enabling standardized preparation, strict quality control, and scalable production of high-quality cells, ensuring reliable and reproducible outcomes for both research and clinical applications. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, reported that six first-in-class cell and gene therapies were introduced in 2023, marking a 50% increase compared to the three introduced in 2022. Therefore, the surge in cell therapy research activities is propelling the growth of the cell therapy processing market.

Companies in the cell therapy processing market are introducing technological innovations such as integrated bioreactor-centrifuge systems to enhance workflow efficiency, scalability, and sterility in manufacturing. An integrated bioreactor-centrifuge system combines cell incubation and centrifugal separation in a single closed unit, enabling continuous, automated processing without the need for intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based cell and gene therapy (CGT) manufacturer, launched LimONE, an automated closed-system platform for cell therapy manufacturing. LimONE integrates hardware, single-use consumables, and software protocols to consolidate critical steps such as incubation, centrifugation, and reagent handling within a compact unit. This innovation allows for consistent and scalable production of advanced therapies, including CAR-T and gene-edited stem cells, from early research through to GMP-compliant manufacturing, eliminating the need for complex technology transfers.

In May 2025, AstraZeneca PLC, a UK-based pharmaceutical company, acquired ESO Biotech for $1 billion. This acquisition was aimed at expanding AstraZeneca's rare disease portfolio by integrating ESO Biotech's advanced gene-editing technologies to strengthen its genomic medicine capabilities. ESO Biotech is a Belgium-based biotechnology company that develops next-generation gene-editing therapies for rare diseases.

Major players in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Nkarta Inc., Cellares Corporation, Cellectis S.A., JW (Cayman) Therapeutics Company Limited, Cell Therapies Pty Ltd., and InGeneron Inc.

North America was the largest region in the cell therapy processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell therapy processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell therapy processing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell therapy processing market consists of revenues earned by entities by providing services such as cell isolation, enrichment services, cell expansion, cryopreservation, and cell characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell therapy processing market also includes sales of cell culture bioreactors, cell counting analyzer, flow cytometers, and viral vector production systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Processing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy processing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy processing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy processing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Offering Type: Products; Services; Software
2) By Applications: Cardiovascular Devices; Bone Repair; Neurological Disorders; Skeletal Muscle Repair; Cancer; Other Applications
3) By End-User: Research Institutes; Biopharmaceutical Companies; Contract Research Organizations; Other End-Users
Subsegments:
1) By Products: Cell Processing Systems; Cell Separation Devices; Cell Culture Equipment; Cell Preservation Systems; Consumables And Reagents
2) By Services: Contract Manufacturing Services; Process Development Services; Quality Control And Testing Services; Logistics And Supply Chain Services; Regulatory Compliance And Documentation Services
3) By Software: Cell Processing Workflow Management Software; Data Analysis And Reporting Software; Quality Management Software; Laboratory Information Management Systems (LIMS); Compliance And Audit Management Software
Companies Mentioned: Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Novartis AG; Gilead Sciences Inc.; Danaher Corporation; Lonza Group AG; Anterogen Co. Ltd.; Terumo Corporation; Sartorius AG; Bio-Techne Corporation; STEMCELL Technologies Inc.; Miltenyi Biotec GmbH; AGC Biologics S.p.A.; MaxCyte Inc.; Nkarta Inc.; Cellares Corporation; Cellectis S.A.; JW (Cayman) Therapeutics Company Limited; Cell Therapies Pty Ltd.; InGeneron Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37715

1. Executive Summary

2. Cell Therapy Processing Market Characteristics

3. Cell Therapy Processing Market Trends And Strategies

4. Cell Therapy Processing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell Therapy Processing Growth Analysis And Strategic Analysis Framework

5.1. Global Cell Therapy Processing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell Therapy Processing Market Growth Rate Analysis
5.4. Global Cell Therapy Processing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell Therapy Processing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell Therapy Processing Total Addressable Market (TAM)

6. Cell Therapy Processing Market Segmentation

6.1. Global Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Products
Services
Software
6.2. Global Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Devices
Bone Repair
Neurological Disorders
Skeletal Muscle Repair
Cancer
Other Applications
6.3. Global Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Other End-Users
6.4. Global Cell Therapy Processing Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Processing Systems
Cell Separation Devices
Cell Culture Equipment
Cell Preservation Systems
Consumables And Reagents
6.5. Global Cell Therapy Processing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Contract Manufacturing Services
Process Development Services
Quality Control And Testing Services
Logistics And Supply Chain Services
Regulatory Compliance And Documentation Services
6.6. Global Cell Therapy Processing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Processing Workflow Management Software
Data Analysis And Reporting Software
Quality Management Software
Laboratory Information Management Systems (LIMS)
Compliance And Audit Management Software

7. Cell Therapy Processing Market Regional And Country Analysis

7.1. Global Cell Therapy Processing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell Therapy Processing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Therapy Processing Market

8.1. Asia-Pacific Cell Therapy Processing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Therapy Processing Market

9.1. China Cell Therapy Processing Market Overview
9.2. China Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Therapy Processing Market

10.1. India Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Therapy Processing Market

11.1. Japan Cell Therapy Processing Market Overview
11.2. Japan Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Therapy Processing Market

12.1. Australia Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Therapy Processing Market

13.1. Indonesia Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Therapy Processing Market

14.1. South Korea Cell Therapy Processing Market Overview
14.2. South Korea Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Therapy Processing Market

15.1. Western Europe Cell Therapy Processing Market Overview
15.2. Western Europe Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Therapy Processing Market

16.1. UK Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Therapy Processing Market

17.1. Germany Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Therapy Processing Market

18.1. France Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Therapy Processing Market

19.1. Italy Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Therapy Processing Market

20.1. Spain Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Therapy Processing Market

21.1. Eastern Europe Cell Therapy Processing Market Overview
21.2. Eastern Europe Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Therapy Processing Market

22.1. Russia Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Therapy Processing Market

23.1. North America Cell Therapy Processing Market Overview
23.2. North America Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Therapy Processing Market

24.1. USA Cell Therapy Processing Market Overview
24.2. USA Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Therapy Processing Market

25.1. Canada Cell Therapy Processing Market Overview
25.2. Canada Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Therapy Processing Market

26.1. South America Cell Therapy Processing Market Overview
26.2. South America Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Therapy Processing Market

27.1. Brazil Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Therapy Processing Market

28.1. Middle East Cell Therapy Processing Market Overview
28.2. Middle East Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Therapy Processing Market

29.1. Africa Cell Therapy Processing Market Overview
29.2. Africa Cell Therapy Processing Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cell Therapy Processing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cell Therapy Processing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Therapy Processing Market Competitive Landscape And Company Profiles

30.1. Cell Therapy Processing Market Competitive Landscape
30.2. Cell Therapy Processing Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell Therapy Processing Market Other Major And Innovative Companies

31.1. Danaher Corporation
31.2. Lonza Group AG
31.3. Anterogen Co. Ltd.
31.4. Terumo Corporation
31.5. Sartorius AG
31.6. Bio-Techne Corporation
31.7. STEMCELL Technologies Inc.
31.8. Miltenyi Biotec GmbH
31.9. AGC Biologics S.p.A.
31.10. MaxCyte Inc.
31.11. Nkarta Inc.
31.12. Cellares Corporation
31.13. Cellectis S.A.
31.14. JW (Cayman) Therapeutics Company Limited
31.15. Cell Therapies Pty Ltd.

32. Global Cell Therapy Processing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Therapy Processing Market

34. Recent Developments In The Cell Therapy Processing Market

35. Cell Therapy Processing Market High Potential Countries, Segments and Strategies

35.1 Cell Therapy Processing Market In 2029 - Countries Offering Most New Opportunities
35.2 Cell Therapy Processing Market In 2029 - Segments Offering Most New Opportunities
35.3 Cell Therapy Processing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer